2026 Q2 -tulosraportti
Vain PDF
13 päivää sitten
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 25 | - | - | ||
| 1 475 | - | - | ||
| 5 822 | - | - | ||
| 3 161 | - | - | ||
| 2 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·5 t sittenstock status Weed.de : A couple of hours passed and then the mentioned pharmacy was sold out again. It hasn't gotten the oil back in stock. Medcanonestop ; Has gone from 4 to 3 pharmacies. Canngo: Has gone from 6 to 5 pharmacies There are still sales of Weeco Astrum 10/10 but right now there is a high probability that people can only buy 1 bottle at a time, because the authorities in Germany who are supposed to release the batch we are waiting for are overwhelmed. Because after the clarification on July 29, there was an extremely large demand for cannabis oil, including Weeco Astrum 10/10. I cannot find so much as a single media outlet writing about the above, that there is a shortage of cannabis oils emerging in Germany. As for Weeco Pharma and the other distributors, who are keeping a low profile about this, it is simply because they do not want to risk also becoming a burden on politicians, so that the oil is also banned. The pharmacies are also not saying anything, because their lobbying that only those people who were actually sick should retain the subsidy for flower medicine also went wrong, because politicians used their argument to stop all subsidies. I am writing the whole story about the pharmacies' failed lobbying below, if you want to read it. The companies that sell flower medicine and who have been lobbying that the people who have now lost their subsidy for flowers and whose quality of life is deteriorating. They are also not interested in it coming out if it turns out that people's quality of life is not deteriorating after all, when they use oils as a substitute for flowers. These are the reasons why everyone agrees to be silent about the authorities not being able to keep up, about there being long waiting times for the release of medical cannabis. This silence is deadly for us (me) shareholders. It is yet another reason why I perform stock status checks, because even if the others are silent, we can see in real-time that Weeco Astrum 10/10 is actually being sold in Germany.To understand why pharmacists have been against flower medicine being legalized, it is important to know that pharmacists have a very high status in Germany. God, the president, and just below the president, the pharmacist. In addition to the pharmacists, there were, among others, two politicians who stood by the pharmacists and were ardent opponents of flower medicine being eligible for subsidy. Nina Warken Minister of Health CDU and Hendrik Streeck (professor of virology and doctor) Commissioner for Drugs and Addiction also of the CDU party. For the other politicians, who were in favor of legalization, to get the bill passed, they entered into a compromise that there should be an ongoing and rigorous evaluation of flower medicine as data became known. (This is a simplified version of the compromise) What then happened with the pharmacists afterwards was that they earned money like never before. Both by selling the flower medicine and by mixing it themselves according to the doctors' instructions. So now they were in a huge dilemma. They wanted to receive money from the flower medicine, but they also couldn't live with the huge loss of prestige it entailed when they were called pushers in white coats. Therefore, they got the cunning idea that they would sit between two chairs, led by Thomas "Preis the chairman of the pharmacists' association", and start lobbying for politicians to ban telemedicine and all sales of flowers from there, so that only people who were truly ill, from the pharmacists' point of view, who needed the flower medicine, would have to stand face to face with their own doctor, so that they could assess the few patients, again from the pharmacists' point of view, who needed flower medicine would receive subsidies for flowers from the health insurance funds. In this way, the pharmacists would maintain their status in society, while also earning money from flower medicine and mixing it themselves according to the doctor's instructions. But that's not how it went. It never does, when you sit between two chairs, because then you fall through. The pharmacists also fell through with a huge bang. Because what happened was that the German politicians, who were against the subsidy for flowers, led by Nina and Henrik, used the pharmacists' arguments as a trampoline, and also that the coffers were empty, to get all subsidies for flower medicine removed, and in the same bill, the politicians had also removed a large part of the profit that the pharmacists received every time they mixed oils and flowers according to doctors' prescriptions. In the same bill, the politicians approved that factory-mixed standardized cannabis oil should be preferred instead. The pharmacists are naturally not satisfied with the above, because after July 29, when it was carved in stone that the subsidy was removed, and that politicians want factory-mixed standardized oils, as a cheaper alternative than pharmacists mixing cannabis, according to the doctor's instructions. So much for being a snob, and that prestige is more important than money, until you lose them, of course. Link to documentary film that made me wonder why the pharmacist had a puzzled face, when he has never earned as much money as he has from flower medicine https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae- ·1 päivä sittenstock status Weed.de has for at least 3 weeks only had 3 pharmacies that have had the oil in stock. Now they have 4 pharmacies that have the oil in stock. I'm crossing my fingers that this is a sign that Weeco Pharma has succeeded in getting the batch released. The reason it has taken so long is that the German system that must approve the oil for sale is under pressure, after clarification on July 29. If the batch is not approved, then it must mean that this pharmacy has received approval to buy internally, probably the pharmacy in Hambrug.From 3 to 4 pharmacies. Wow. There is actually an increase of a massive 33.3%. I think you can already see the outlines of the next upward revision? And the director is just silent? It's already starting to be suspicious. Hope you have the report to the Financial Supervisory Authority ready, it's just a date you need to correct on the last one you wrote. "Probably the pharmacy in Hamburg" you write. I think your status reports now sound more like some that come from the pharmacy in Humbug.
- ·1 päivä sittenOnly for those of you who don't know anything about the French market and would like to gain more knowledge. As is always the case in this industry, it's complicated, so it will be an ongoing process where we gradually become wiser about what's happening in France. There has been so much turbulence in Germany that, for my part, France has been pushed a bit into the background. But now that French politicians are returning from their summer holidays on Monday. And since everyone in Germany is taking a break, I thought I would take the opportunity to look into why PJ and TS have stated that they expect France to become a valuable market for Stenocare. Stenocare has two agreements in France. One is Institut des Cannabinoïdes Médicaux Français, the other is the distribution giant Movianto (see link below) Stenocare has, via ICMF, sent an application to HAS, because HAS has opened up for early application of medical cannabis. These companies have two different purposes. ICMF ICMF specializes in helping companies write applications, in this case, to the French "HAS" to ensure this is done correctly the first time. Movianto is one of the largest distributors in France. They state on their website: " leading specialist in supply chains within the healthcare and pharmaceutical sectors" What strikes me is that it is the pharmaceutical sector they specialize in. And as is well known, the devil is in the details. Movianto has approval to sell pharmaceutical and standardized medicines and not medical cannabis. Therefore, Astrum 10/10 can only be approved as a pharmaceutical and standardized medicine, and not cannabis medicine in France. The President has not signed yet, but it is expected to happen later and to be announced on October 1st. After that, the process towards final approval will proceed "ICMF" Their website is down, https://icmf.fr/ Movianto https://movianto.com/locations/france/ Announcement of cooperation with the above. https://www.inderes.dk/en/releases/stenocare-as-positions-for-first-mover-advantage-in-france-with-strategic-partnership-product-filing-and-national-distribution-partnership
- ·2 päivää sittenFrance has gone through a longer pilot project period, regarding medical cannabis. Concurrently, research has apparently been conducted into whether cannabis medicine could replace other medicine. They found out that it could. The study has proven that medical cannabis has reduced the consumption of opioids. After this study has emerged, French politicians have become more favorably disposed towards medical cannabis, therefore they want the pilot project to become a permanent scheme. For this reason, there will hardly be anyone who will put a spoke in the wheel to prevent the president from signing the decree, which is planned for this September. As I have written previously, flower medicine does not receive subsidies. But standardized oil, such as Astrum 10/10, will be approved for sale and receive 100% reimbursement. https://businessofcannabis.com/france-sets-july-deadline-for-medical-cannabis-regulations-as-withheld-study-shows-opioid-reductions/There is nothing decisively new to report about France. The post is only about 3D feeling a need to write something about stenocare every day and all the time.
- ·3 päivää sittenA bit of gossip from Germany while we wait for the batch to be released. There has just been a lawsuit in Frankfurt, where a woman wanted to have the opportunity to retain her status in the healthcare system regarding flower medicine. She did not win. By mistake or perhaps it was lobbying, it was also interpreted as if she and all others who had been treated with flower medicine after this ruling should be considered new patients, and then would have to go into quarantine anyway. This has been rectified again, and as of August 28th, a message has been sent out that these patient groups are free from quarantine. As long as those who have been treated with flowers before July 30th are free from quarantine, then it's good for Weeco Astrum10/10 because more bottles will be handed over the counter from this segment. https://bdcan.de/cannabisblueten-gkv/
Admitted, I was cracking up, sorry. But it was good. I'm into good humor, after all
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 13 267 | 13 267 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 13 267 | 13 267 | 0 | 0 |
2026 Q2 -tulosraportti
Vain PDF
13 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenstock status Weed.de : A couple of hours passed and then the mentioned pharmacy was sold out again. It hasn't gotten the oil back in stock. Medcanonestop ; Has gone from 4 to 3 pharmacies. Canngo: Has gone from 6 to 5 pharmacies There are still sales of Weeco Astrum 10/10 but right now there is a high probability that people can only buy 1 bottle at a time, because the authorities in Germany who are supposed to release the batch we are waiting for are overwhelmed. Because after the clarification on July 29, there was an extremely large demand for cannabis oil, including Weeco Astrum 10/10. I cannot find so much as a single media outlet writing about the above, that there is a shortage of cannabis oils emerging in Germany. As for Weeco Pharma and the other distributors, who are keeping a low profile about this, it is simply because they do not want to risk also becoming a burden on politicians, so that the oil is also banned. The pharmacies are also not saying anything, because their lobbying that only those people who were actually sick should retain the subsidy for flower medicine also went wrong, because politicians used their argument to stop all subsidies. I am writing the whole story about the pharmacies' failed lobbying below, if you want to read it. The companies that sell flower medicine and who have been lobbying that the people who have now lost their subsidy for flowers and whose quality of life is deteriorating. They are also not interested in it coming out if it turns out that people's quality of life is not deteriorating after all, when they use oils as a substitute for flowers. These are the reasons why everyone agrees to be silent about the authorities not being able to keep up, about there being long waiting times for the release of medical cannabis. This silence is deadly for us (me) shareholders. It is yet another reason why I perform stock status checks, because even if the others are silent, we can see in real-time that Weeco Astrum 10/10 is actually being sold in Germany.To understand why pharmacists have been against flower medicine being legalized, it is important to know that pharmacists have a very high status in Germany. God, the president, and just below the president, the pharmacist. In addition to the pharmacists, there were, among others, two politicians who stood by the pharmacists and were ardent opponents of flower medicine being eligible for subsidy. Nina Warken Minister of Health CDU and Hendrik Streeck (professor of virology and doctor) Commissioner for Drugs and Addiction also of the CDU party. For the other politicians, who were in favor of legalization, to get the bill passed, they entered into a compromise that there should be an ongoing and rigorous evaluation of flower medicine as data became known. (This is a simplified version of the compromise) What then happened with the pharmacists afterwards was that they earned money like never before. Both by selling the flower medicine and by mixing it themselves according to the doctors' instructions. So now they were in a huge dilemma. They wanted to receive money from the flower medicine, but they also couldn't live with the huge loss of prestige it entailed when they were called pushers in white coats. Therefore, they got the cunning idea that they would sit between two chairs, led by Thomas "Preis the chairman of the pharmacists' association", and start lobbying for politicians to ban telemedicine and all sales of flowers from there, so that only people who were truly ill, from the pharmacists' point of view, who needed the flower medicine, would have to stand face to face with their own doctor, so that they could assess the few patients, again from the pharmacists' point of view, who needed flower medicine would receive subsidies for flowers from the health insurance funds. In this way, the pharmacists would maintain their status in society, while also earning money from flower medicine and mixing it themselves according to the doctor's instructions. But that's not how it went. It never does, when you sit between two chairs, because then you fall through. The pharmacists also fell through with a huge bang. Because what happened was that the German politicians, who were against the subsidy for flowers, led by Nina and Henrik, used the pharmacists' arguments as a trampoline, and also that the coffers were empty, to get all subsidies for flower medicine removed, and in the same bill, the politicians had also removed a large part of the profit that the pharmacists received every time they mixed oils and flowers according to doctors' prescriptions. In the same bill, the politicians approved that factory-mixed standardized cannabis oil should be preferred instead. The pharmacists are naturally not satisfied with the above, because after July 29, when it was carved in stone that the subsidy was removed, and that politicians want factory-mixed standardized oils, as a cheaper alternative than pharmacists mixing cannabis, according to the doctor's instructions. So much for being a snob, and that prestige is more important than money, until you lose them, of course. Link to documentary film that made me wonder why the pharmacist had a puzzled face, when he has never earned as much money as he has from flower medicine https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
- ·1 päivä sittenstock status Weed.de has for at least 3 weeks only had 3 pharmacies that have had the oil in stock. Now they have 4 pharmacies that have the oil in stock. I'm crossing my fingers that this is a sign that Weeco Pharma has succeeded in getting the batch released. The reason it has taken so long is that the German system that must approve the oil for sale is under pressure, after clarification on July 29. If the batch is not approved, then it must mean that this pharmacy has received approval to buy internally, probably the pharmacy in Hambrug.From 3 to 4 pharmacies. Wow. There is actually an increase of a massive 33.3%. I think you can already see the outlines of the next upward revision? And the director is just silent? It's already starting to be suspicious. Hope you have the report to the Financial Supervisory Authority ready, it's just a date you need to correct on the last one you wrote. "Probably the pharmacy in Hamburg" you write. I think your status reports now sound more like some that come from the pharmacy in Humbug.
- ·1 päivä sittenOnly for those of you who don't know anything about the French market and would like to gain more knowledge. As is always the case in this industry, it's complicated, so it will be an ongoing process where we gradually become wiser about what's happening in France. There has been so much turbulence in Germany that, for my part, France has been pushed a bit into the background. But now that French politicians are returning from their summer holidays on Monday. And since everyone in Germany is taking a break, I thought I would take the opportunity to look into why PJ and TS have stated that they expect France to become a valuable market for Stenocare. Stenocare has two agreements in France. One is Institut des Cannabinoïdes Médicaux Français, the other is the distribution giant Movianto (see link below) Stenocare has, via ICMF, sent an application to HAS, because HAS has opened up for early application of medical cannabis. These companies have two different purposes. ICMF ICMF specializes in helping companies write applications, in this case, to the French "HAS" to ensure this is done correctly the first time. Movianto is one of the largest distributors in France. They state on their website: " leading specialist in supply chains within the healthcare and pharmaceutical sectors" What strikes me is that it is the pharmaceutical sector they specialize in. And as is well known, the devil is in the details. Movianto has approval to sell pharmaceutical and standardized medicines and not medical cannabis. Therefore, Astrum 10/10 can only be approved as a pharmaceutical and standardized medicine, and not cannabis medicine in France. The President has not signed yet, but it is expected to happen later and to be announced on October 1st. After that, the process towards final approval will proceed "ICMF" Their website is down, https://icmf.fr/ Movianto https://movianto.com/locations/france/ Announcement of cooperation with the above. https://www.inderes.dk/en/releases/stenocare-as-positions-for-first-mover-advantage-in-france-with-strategic-partnership-product-filing-and-national-distribution-partnership
- ·2 päivää sittenFrance has gone through a longer pilot project period, regarding medical cannabis. Concurrently, research has apparently been conducted into whether cannabis medicine could replace other medicine. They found out that it could. The study has proven that medical cannabis has reduced the consumption of opioids. After this study has emerged, French politicians have become more favorably disposed towards medical cannabis, therefore they want the pilot project to become a permanent scheme. For this reason, there will hardly be anyone who will put a spoke in the wheel to prevent the president from signing the decree, which is planned for this September. As I have written previously, flower medicine does not receive subsidies. But standardized oil, such as Astrum 10/10, will be approved for sale and receive 100% reimbursement. https://businessofcannabis.com/france-sets-july-deadline-for-medical-cannabis-regulations-as-withheld-study-shows-opioid-reductions/There is nothing decisively new to report about France. The post is only about 3D feeling a need to write something about stenocare every day and all the time.
- ·3 päivää sittenA bit of gossip from Germany while we wait for the batch to be released. There has just been a lawsuit in Frankfurt, where a woman wanted to have the opportunity to retain her status in the healthcare system regarding flower medicine. She did not win. By mistake or perhaps it was lobbying, it was also interpreted as if she and all others who had been treated with flower medicine after this ruling should be considered new patients, and then would have to go into quarantine anyway. This has been rectified again, and as of August 28th, a message has been sent out that these patient groups are free from quarantine. As long as those who have been treated with flowers before July 30th are free from quarantine, then it's good for Weeco Astrum10/10 because more bottles will be handed over the counter from this segment. https://bdcan.de/cannabisblueten-gkv/Admitted, I was cracking up, sorry. But it was good. I'm into good humor, after all
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 25 | - | - | ||
| 1 475 | - | - | ||
| 5 822 | - | - | ||
| 3 161 | - | - | ||
| 2 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 13 267 | 13 267 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 13 267 | 13 267 | 0 | 0 |
2026 Q2 -tulosraportti
Vain PDF
13 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 20.8. | ||
2026 Q1 -tulosraportti 7.5. | ||
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 22.10.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sittenstock status Weed.de : A couple of hours passed and then the mentioned pharmacy was sold out again. It hasn't gotten the oil back in stock. Medcanonestop ; Has gone from 4 to 3 pharmacies. Canngo: Has gone from 6 to 5 pharmacies There are still sales of Weeco Astrum 10/10 but right now there is a high probability that people can only buy 1 bottle at a time, because the authorities in Germany who are supposed to release the batch we are waiting for are overwhelmed. Because after the clarification on July 29, there was an extremely large demand for cannabis oil, including Weeco Astrum 10/10. I cannot find so much as a single media outlet writing about the above, that there is a shortage of cannabis oils emerging in Germany. As for Weeco Pharma and the other distributors, who are keeping a low profile about this, it is simply because they do not want to risk also becoming a burden on politicians, so that the oil is also banned. The pharmacies are also not saying anything, because their lobbying that only those people who were actually sick should retain the subsidy for flower medicine also went wrong, because politicians used their argument to stop all subsidies. I am writing the whole story about the pharmacies' failed lobbying below, if you want to read it. The companies that sell flower medicine and who have been lobbying that the people who have now lost their subsidy for flowers and whose quality of life is deteriorating. They are also not interested in it coming out if it turns out that people's quality of life is not deteriorating after all, when they use oils as a substitute for flowers. These are the reasons why everyone agrees to be silent about the authorities not being able to keep up, about there being long waiting times for the release of medical cannabis. This silence is deadly for us (me) shareholders. It is yet another reason why I perform stock status checks, because even if the others are silent, we can see in real-time that Weeco Astrum 10/10 is actually being sold in Germany.To understand why pharmacists have been against flower medicine being legalized, it is important to know that pharmacists have a very high status in Germany. God, the president, and just below the president, the pharmacist. In addition to the pharmacists, there were, among others, two politicians who stood by the pharmacists and were ardent opponents of flower medicine being eligible for subsidy. Nina Warken Minister of Health CDU and Hendrik Streeck (professor of virology and doctor) Commissioner for Drugs and Addiction also of the CDU party. For the other politicians, who were in favor of legalization, to get the bill passed, they entered into a compromise that there should be an ongoing and rigorous evaluation of flower medicine as data became known. (This is a simplified version of the compromise) What then happened with the pharmacists afterwards was that they earned money like never before. Both by selling the flower medicine and by mixing it themselves according to the doctors' instructions. So now they were in a huge dilemma. They wanted to receive money from the flower medicine, but they also couldn't live with the huge loss of prestige it entailed when they were called pushers in white coats. Therefore, they got the cunning idea that they would sit between two chairs, led by Thomas "Preis the chairman of the pharmacists' association", and start lobbying for politicians to ban telemedicine and all sales of flowers from there, so that only people who were truly ill, from the pharmacists' point of view, who needed the flower medicine, would have to stand face to face with their own doctor, so that they could assess the few patients, again from the pharmacists' point of view, who needed flower medicine would receive subsidies for flowers from the health insurance funds. In this way, the pharmacists would maintain their status in society, while also earning money from flower medicine and mixing it themselves according to the doctor's instructions. But that's not how it went. It never does, when you sit between two chairs, because then you fall through. The pharmacists also fell through with a huge bang. Because what happened was that the German politicians, who were against the subsidy for flowers, led by Nina and Henrik, used the pharmacists' arguments as a trampoline, and also that the coffers were empty, to get all subsidies for flower medicine removed, and in the same bill, the politicians had also removed a large part of the profit that the pharmacists received every time they mixed oils and flowers according to doctors' prescriptions. In the same bill, the politicians approved that factory-mixed standardized cannabis oil should be preferred instead. The pharmacists are naturally not satisfied with the above, because after July 29, when it was carved in stone that the subsidy was removed, and that politicians want factory-mixed standardized oils, as a cheaper alternative than pharmacists mixing cannabis, according to the doctor's instructions. So much for being a snob, and that prestige is more important than money, until you lose them, of course. Link to documentary film that made me wonder why the pharmacist had a puzzled face, when he has never earned as much money as he has from flower medicine https://www.tv2kosmopol.dk/metropolen/gadepusheren-har-faet-hvid-kittel-pa-reporter-far-laegerecept-pa-cannabis-pa-fa-minutter-555ae
- ·1 päivä sittenstock status Weed.de has for at least 3 weeks only had 3 pharmacies that have had the oil in stock. Now they have 4 pharmacies that have the oil in stock. I'm crossing my fingers that this is a sign that Weeco Pharma has succeeded in getting the batch released. The reason it has taken so long is that the German system that must approve the oil for sale is under pressure, after clarification on July 29. If the batch is not approved, then it must mean that this pharmacy has received approval to buy internally, probably the pharmacy in Hambrug.From 3 to 4 pharmacies. Wow. There is actually an increase of a massive 33.3%. I think you can already see the outlines of the next upward revision? And the director is just silent? It's already starting to be suspicious. Hope you have the report to the Financial Supervisory Authority ready, it's just a date you need to correct on the last one you wrote. "Probably the pharmacy in Hamburg" you write. I think your status reports now sound more like some that come from the pharmacy in Humbug.
- ·1 päivä sittenOnly for those of you who don't know anything about the French market and would like to gain more knowledge. As is always the case in this industry, it's complicated, so it will be an ongoing process where we gradually become wiser about what's happening in France. There has been so much turbulence in Germany that, for my part, France has been pushed a bit into the background. But now that French politicians are returning from their summer holidays on Monday. And since everyone in Germany is taking a break, I thought I would take the opportunity to look into why PJ and TS have stated that they expect France to become a valuable market for Stenocare. Stenocare has two agreements in France. One is Institut des Cannabinoïdes Médicaux Français, the other is the distribution giant Movianto (see link below) Stenocare has, via ICMF, sent an application to HAS, because HAS has opened up for early application of medical cannabis. These companies have two different purposes. ICMF ICMF specializes in helping companies write applications, in this case, to the French "HAS" to ensure this is done correctly the first time. Movianto is one of the largest distributors in France. They state on their website: " leading specialist in supply chains within the healthcare and pharmaceutical sectors" What strikes me is that it is the pharmaceutical sector they specialize in. And as is well known, the devil is in the details. Movianto has approval to sell pharmaceutical and standardized medicines and not medical cannabis. Therefore, Astrum 10/10 can only be approved as a pharmaceutical and standardized medicine, and not cannabis medicine in France. The President has not signed yet, but it is expected to happen later and to be announced on October 1st. After that, the process towards final approval will proceed "ICMF" Their website is down, https://icmf.fr/ Movianto https://movianto.com/locations/france/ Announcement of cooperation with the above. https://www.inderes.dk/en/releases/stenocare-as-positions-for-first-mover-advantage-in-france-with-strategic-partnership-product-filing-and-national-distribution-partnership
- ·2 päivää sittenFrance has gone through a longer pilot project period, regarding medical cannabis. Concurrently, research has apparently been conducted into whether cannabis medicine could replace other medicine. They found out that it could. The study has proven that medical cannabis has reduced the consumption of opioids. After this study has emerged, French politicians have become more favorably disposed towards medical cannabis, therefore they want the pilot project to become a permanent scheme. For this reason, there will hardly be anyone who will put a spoke in the wheel to prevent the president from signing the decree, which is planned for this September. As I have written previously, flower medicine does not receive subsidies. But standardized oil, such as Astrum 10/10, will be approved for sale and receive 100% reimbursement. https://businessofcannabis.com/france-sets-july-deadline-for-medical-cannabis-regulations-as-withheld-study-shows-opioid-reductions/There is nothing decisively new to report about France. The post is only about 3D feeling a need to write something about stenocare every day and all the time.
- ·3 päivää sittenA bit of gossip from Germany while we wait for the batch to be released. There has just been a lawsuit in Frankfurt, where a woman wanted to have the opportunity to retain her status in the healthcare system regarding flower medicine. She did not win. By mistake or perhaps it was lobbying, it was also interpreted as if she and all others who had been treated with flower medicine after this ruling should be considered new patients, and then would have to go into quarantine anyway. This has been rectified again, and as of August 28th, a message has been sent out that these patient groups are free from quarantine. As long as those who have been treated with flowers before July 30th are free from quarantine, then it's good for Weeco Astrum10/10 because more bottles will be handed over the counter from this segment. https://bdcan.de/cannabisblueten-gkv/Admitted, I was cracking up, sorry. But it was good. I'm into good humor, after all
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 25 | - | - | ||
| 1 475 | - | - | ||
| 5 822 | - | - | ||
| 3 161 | - | - | ||
| 2 000 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 13 267 | 13 267 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 13 267 | 13 267 | 0 | 0 |